May/June 2016

 

In this Issue

The State of the Art

Issue

Insert

View the E-Dition

UP FRONT

The Gift of Mentorship

By Steven D. Vold, MD

THE LITERATURE

The Literature

By Reena A. Garg, MD, and Helen Jiang, MD

PEER REVIEW

Detecting and Treating Glaucoma in a Myopic Patient Without High IOP

By Robert Chang, MD, and Kuldev Singh, MD, MPH

THERAPEUTICS UPDATE

Revisiting Risk

It is time to take a fresh look at carbonic anhydrase inhibitors and sulfonamide allergy.

By Jeff Martow, MDCM, FRCSC; Evan Martow, BMSc, MDCM; and Mattan Lustgarten, BSc

CHALLENGING CASES

Managing a Failed Trabeculectomy

By Sandra M. Johnson, MD, and Eric Areiter, MD

INTERNATIONAL PERSPECTIVES

The Eyes of Africa Project

Partners bring comprehensive eye care to rural Malawi.

By William Eric Sponsel, MD

COVER FOCUS:

Diagnostic Testing

The Future Is Now

The era of 24-hour IOP monitoring is upon us.

By Kaweh Mansouri, MD, MPH

Assessing Corneal Biomechanics

The importance of these properties rests primarily with their effects on IOP measurement.

By Leon W. Herndon, MD

Evaluating Quality of Life in Glaucoma

Understand the impact of the disease to improve care.

By Felipe A. Medeiros, MD, PhD

The Next Step in Visual Fields

Home testing procedures and real-world, task-related performance methods are needed.

By Chris A. Johnson, PhD, DSc

Do We Need Perimetry?

As glaucoma advances, visual field testing provides valuable insight.

By Murray Fingeret, OD

Enhancing Visual Field Testing

Techniques to increase the value and reliability of visual fields.

By Oluwatosin Smith, MD

Visual Fields as Screening Tools

Problems remain, but this form of testing allows physicians to accurately assess glaucoma’s impact on patients’ vision.

By Jeffrey D. Henderer, MD

Pitfalls in Optical Coherence Tomography Imaging

Essentials for correct interpretation.

By Sanjay Asrani, MD

Where Does Ganglion Cell Analysis Fit?

The role of macular optical coherence tomography in glaucoma assessment.

By Hiroshi Ishikawa, MD

The Role of Optic Nerve Head Imaging

Past, present, and future.

By Anitra Turner, MD, and Anjali Bhorade, MD, MSCI

RNFL Analysis in the Diagnosis of Glaucoma

Measuring peripapillary retinal nerve fiber layer thickness with spectral-domain optical coherence tomography provides an objective and reliable estimate of glaucomatous optic nerve damage.

By Luis E. Vazquez, MD, PhD, and Linda Y. Huang, MD

Optical Coherence Tomography as a Glaucoma Screening Tool

Does it affect glaucoma detection in the community?

By Lisa F. Rosenberg, MD, and Casey Cahill, MD

Is There Still a Role for Optic Disc Photography?

New is not necessarily better.

By George L. Spaeth, MD; Kamran Rahmatnejad, MD; and Lichuan Zeng, BSE

The Promise of Genetic Testing

Research may improve the diagnosis and treatment of glaucoma.

By John Fingert, MD, PhD

RESIDENTS AND FELLOWS

Fighting Side by Side

By Sze H. Wong, MD

PRACTICE POINTERS

Down, But Not Out: How the AAO Has Responded to Medicare's 2016 Ophthalmology Fee Cuts

Faced with cuts to ophthalmic reimbursements, the American Academy of Ophthalmology sprang into action.

By George A. Williams, MD

IN BACK

Industry News

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.